Ted Singer retweeted
PeerView was proud to share the impressive results of collaborative educational initiatives with @CllSociety at #ASH23 Sunday! These initiatives led to significant improvements in healthcare professionals' knowledge, skills, and intentions regarding #CLL patient care #MedEd
Ted Singer retweeted
Review case examples to see how experts @desaimilindy & @tikuowens assess patient candidacy for cardiac myosin inhibitors and monitor therapy for #HCM. Join them this Sunday, 10/8, at 6:45 AM EDT during #HFSA2023! bit.ly/2023HCMT #MedEd #Cardiology #MedTwitter @HFSA
Ted Singer retweeted
Witness case examples to see how experts @desaimilindy & @tikuowens assess patient candidacy for cardiac myosin inhibitors and monitor therapy for #HCM. Join them at #HSFA2023 this Sunday at 6:45 AM EDT‼️ bit.ly/2023HCMT #MedEd #Cardiology #MedTwitter @HFSA @PeerView
Ted Singer retweeted
Talking #atopicdermatitis with Drs. Lio & Sidbury @PeerView
Ted Singer retweeted
Amazing opportunity to discuss evolving role of immune therapy in a multidisciplinary setting. Looking forward to the discussion!!
Register now for the May 4th #BreastCancer Symposium: On the Cusp of the Era of Immuno-Oncology in #TNBC with Drs. Elizabeth Mittendorf (@EMittendorfMD), Heather McArthur (@hmcarthur) & Colleague. bit.ly/TNBCresect #ASBrS19 #PeerView
Ted Singer retweeted
Don't miss out. Immunotherapy will become a pillar of treatment for EARLY stage NSCLC. Surgeons need to be in the conversation.
Please join @PeerView for free dinner and CME event! Please pass along to all attending #AATS19. #lcsm
Register early at peerview.com/p/index.html?co…
Ted Singer retweeted
Also open to all trainees attending #AATS2019 in Toronto next weekend!
Don't miss out. Immunotherapy will become a pillar of treatment for EARLY stage NSCLC. Surgeons need to be in the conversation.
Please join @PeerView for free dinner and CME event! Please pass along to all attending #AATS19. #lcsm
Register early at peerview.com/p/index.html?co…













